{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-005211","form_type":"8-K","ticker":"ATPC","cik":"0001713210","company_name":"Agape ATP Corp","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.980177+00:00","generated_at":"2026-05-16T04:29:16.335318+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Agape ATP receives Nasdaq delisting notice for low stock price; plans to appeal","bullets":["Received delisting notice on Feb 2, 2026 under Low Priced Stocks rule (bid ≤ $0.10 for 10 days).","Also non-compliant with minimum bid price of $1.00 per share (Nasdaq Rule 5550(a)(2)).","Will request a hearing by Feb 9, 2026 to stay suspension; hearing fee is $20,000.","Stock trades on Nasdaq Capital Market under symbol ATPC."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-005211","json":"https://secwatch.observer/filing/0001493152-26-005211.json","markdown":"https://secwatch.observer/filing/0001493152-26-005211.md","text":"https://secwatch.observer/filing/0001493152-26-005211.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/0001493152-26-005211-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:29:16.335318+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1b0c8c9fdda3f34cf329e66025d7a71e33b832f6","claim":"Agape ATP Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"January 27, 2026, notifying the Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis for delisting the Company’s securities from Nasdaq. On February 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to del","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/0001493152-26-005211-index.htm","confidence":0.9},{"claim_id":"a00f2f79abb38549ec54e6226d25dd4c53a8374c","claim":"Agape ATP Corp received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).","evidence_excerpt":"February 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to delist the Company’s securities. The Staff’s determination was based on that as of January 30, 2026, the Company’s securities had a closing bid of $0.10 or less for the last ten consecutive trading days, and accordingly, is subject to the provisions under Listing Rule 5810(c)(3)(A)(iii), the “Low Priced Stocks” Rule. The Company has the opportunity to request a hearing with the Hearings Panel (the “Panel”), by February 9, 2026. The Company intends to make the request","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/0001493152-26-005211-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001213900-26-062935","ticker":"ATNM","company_name":"Actinium Pharmaceuticals, Inc.","filed_at":"2026-05-29T21:10:41+00:00","headline":"Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26","event_type":"regulatory","sec_items":["3.01","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 7.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062935","json":"https://secwatch.observer/filing/0001213900-26-062935.json","markdown":"https://secwatch.observer/filing/0001213900-26-062935.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388320/000121390026062935/0001213900-26-062935-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388320/000121390026062935/ea0292691-8k_actinium.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 27, 2026, notifying\nthe Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days,\nthe Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing\non Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis\nfor delisting the Company’s securities from Nasdaq. On\nFebruary 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to del","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/0001493152-26-005211-index.htm","comparable_excerpt":"May 27, 2026, Actinium Pharmaceuticals, Inc.\n(the “Company”) received a notice (the “Notice”) from NYSE American LLC (“NYSE American”) indicating\nthat the Company is not in compliance with the continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company\nGuide (the “Company Guide”), which requires a listed company to maintain stockholders’ equity of $4.0 million or more\nif it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. As of March 31,\n2026, the Company reported stockholders’ equity of approximately","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390026062935/0001213900-26-062935-index.htm"}},{"accession":"0001493152-26-025277","ticker":"VSTD","company_name":"Vestand Inc.","filed_at":"2026-05-26T21:18:59+00:00","headline":"Vestand receives Nasdaq delisting notice for late quarterly and annual filings","event_type":"regulatory","sec_items":["3.01","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 7.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025277","json":"https://secwatch.observer/filing/0001493152-26-025277.json","markdown":"https://secwatch.observer/filing/0001493152-26-025277.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226025277/0001493152-26-025277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226025277/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 27, 2026, notifying\nthe Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days,\nthe Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing\non Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis\nfor delisting the Company’s securities from Nasdaq. On\nFebruary 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to del","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/0001493152-26-005211-index.htm","comparable_excerpt":"May 19, 2026, the Company received a Staff Delisting Determination letter (the “Staff Determination”) from Nasdaq notifying\nit that Nasdaq has initiated a process which could result in the delisting of the Company’s secu","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226025277/0001493152-26-025277-index.htm"}},{"accession":"0001836875-26-000036","ticker":"NVVE","company_name":"Nuvve Holding Corp.","filed_at":"2026-05-22T22:35:13+00:00","headline":"Nuvve receives Nasdaq delisting notice for late Q1 10-Q filing; already under $1.00 bid price review","event_type":"regulatory","sec_items":["3.01","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 7.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001836875-26-000036","json":"https://secwatch.observer/filing/0001836875-26-000036.json","markdown":"https://secwatch.observer/filing/0001836875-26-000036.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1836875/000183687526000036/0001836875-26-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1836875/000183687526000036/nvve-20260522.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 27, 2026, notifying\nthe Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days,\nthe Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing\non Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis\nfor delisting the Company’s securities from Nasdaq. On\nFebruary 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to del","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/0001493152-26-005211-index.htm","comparable_excerpt":"May 22, 2026, Nuvve Holding Corp. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, since the Company","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1836875/000183687526000036/0001836875-26-000036-index.htm"}},{"accession":"0001213900-26-054565","ticker":"AGAE","company_name":"Allied Gaming & Entertainment Inc.","filed_at":"2026-05-11T21:09:36+00:00","headline":"AGAE receives Nasdaq delisting notice over bid price <$1.00 and late 10-K; will appeal","event_type":"regulatory","sec_items":["3.01","5.03","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 7.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-054565","json":"https://secwatch.observer/filing/0001213900-26-054565.json","markdown":"https://secwatch.observer/filing/0001213900-26-054565.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708341/000121390026054565/0001213900-26-054565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708341/000121390026054565/ea0290063-8k_allied.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 27, 2026, notifying\nthe Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days,\nthe Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing\non Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis\nfor delisting the Company’s securities from Nasdaq. On\nFebruary 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to del","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/0001493152-26-005211-index.htm","comparable_excerpt":"termination\nbefore an independent Hearings Panel (the “Panel”) by May 13, 2026. On November 4, 2025, Staff notified the Company\nthat the bid price of the Common Stock had closed at less than $1.00 per share over 30 consecutive business days, and, as a result, did\nnot comply with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). The Staff Determination was issued pursuant\nto Nasdaq Listing Rule 5810(c)(3)(A) on the grounds that the Company has not regained compliance with the Minimum Bid Price Rule during\na 180-day compliance period and is not eligible for a second 180-day complian","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1708341/000121390026054565/0001213900-26-054565-index.htm"}},{"accession":"0001731122-26-000668","ticker":"SBEV","company_name":"SPLASH BEVERAGE GROUP, INC.","filed_at":"2026-05-05T23:59:59+00:00","headline":"Splash Beverage receives NYSE delisting notice; shareholders' equity negative $15.3M","event_type":"regulatory","sec_items":["1.01","1.02","3.01","3.02","5.03","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 7.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000668","json":"https://secwatch.observer/filing/0001731122-26-000668.json","markdown":"https://secwatch.observer/filing/0001731122-26-000668.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000668/0001731122-26-000668-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000668/e7604_8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 27, 2026, notifying\nthe Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days,\nthe Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing\non Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis\nfor delisting the Company’s securities from Nasdaq. On\nFebruary 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to del","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/0001493152-26-005211-index.htm","comparable_excerpt":"April 29, 2026, the Company received notice from NYSE Regulation (the “NYSE”)\nthat the Company is not in compliance with the shareholders’ equity requirement of $6 million as of December 31, 2025 as outlined\nin Section 1","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000668/0001731122-26-000668-index.htm"}},{"accession":"0001493152-26-019609","ticker":"VSTD","company_name":"Vestand Inc.","filed_at":"2026-04-29T23:59:59+00:00","headline":"Vestand receives Nasdaq delisting notice for late 10-K filing; may submit compliance plan by May 18, 2026","event_type":"regulatory","sec_items":["3.01","7.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 7.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-019609","json":"https://secwatch.observer/filing/0001493152-26-019609.json","markdown":"https://secwatch.observer/filing/0001493152-26-019609.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226019609/0001493152-26-019609-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226019609/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 27, 2026, notifying\nthe Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days,\nthe Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing\non Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis\nfor delisting the Company’s securities from Nasdaq. On\nFebruary 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to del","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/0001493152-26-005211-index.htm","comparable_excerpt":"April 23, 2026, Vestand Inc. (the “Company”) received a staff deficiency notice (the “Notice”) from The Nasdaq\nStock Market (“Nasdaq”) indicating that, because Nasdaq has not yet received the Company’s Form 10-K for the","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226019609/0001493152-26-019609-index.htm"}},{"accession":"0001193125-26-179391","ticker":"JAGX","company_name":"Jaguar Health, Inc.","filed_at":"2026-04-27T23:59:59+00:00","headline":"Jaguar Health granted Nasdaq extension to May 15, 2026; announces 1-for-35 reverse stock split","event_type":"regulatory","sec_items":["3.01","3.03","5.03","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 7.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-179391","json":"https://secwatch.observer/filing/0001193125-26-179391.json","markdown":"https://secwatch.observer/filing/0001193125-26-179391.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526179391/0001193125-26-179391-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526179391/d109088d8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 27, 2026, notifying\nthe Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days,\nthe Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing\non Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis\nfor delisting the Company’s securities from Nasdaq. On\nFebruary 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to del","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/0001493152-26-005211-index.htm","comparable_excerpt":"April 24, 2026, Jaguar Health, Inc. (the “Company”) received a decision letter from the Nasdaq Hearings Panel (“Panel”) granting the Company’s request to continue its listing on The Nasdaq Stock Market LLC (“Nasdaq”), su","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526179391/0001193125-26-179391-index.htm"}},{"accession":"0001654954-26-005548","ticker":"ONFO","company_name":"Onfolio Holdings, Inc","filed_at":"2026-05-29T20:30:53+00:00","headline":"Onfolio receives Nasdaq delisting notice for insufficient equity ($1.22M vs $2.5M min)","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-26-005548","json":"https://secwatch.observer/filing/0001654954-26-005548.json","markdown":"https://secwatch.observer/filing/0001654954-26-005548.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1825452/000165495426005548/0001654954-26-005548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1825452/000165495426005548/onfo_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 27, 2026, notifying\nthe Company that, based upon the closing bid price of the Company’s ordinary shares for the last 30 consecutive business days,\nthe Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing\non Nasdaq, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), which matter serves as a basis\nfor delisting the Company’s securities from Nasdaq. On\nFebruary 2, 2026, the Company received an additional Notification Letter notifying the Company that the Staff has determined to del","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1713210/000149315226005211/0001493152-26-005211-index.htm","comparable_excerpt":"May 26, 2026, Onfolio Holdings Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) informing the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market. The Notice states that the Company’s Quarterly Report on Form 10-Q for the for the period ended March 31, 2026 reported stockholders’ equity of $1,216,603. As of the date of the Notice","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1825452/000165495426005548/0001654954-26-005548-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}